Comprehensive analyses of circulating cardiometabolic proteins and objective measures of fat mass.
Journal
International journal of obesity (2005)
ISSN: 1476-5497
Titre abrégé: Int J Obes (Lond)
Pays: England
ID NLM: 101256108
Informations de publication
Date de publication:
11 2023
11 2023
Historique:
received:
07
03
2023
accepted:
14
07
2023
revised:
03
07
2023
medline:
27
10
2023
pubmed:
8
8
2023
entrez:
7
8
2023
Statut:
ppublish
Résumé
The underlying molecular pathways for the effect of excess fat mass on cardiometabolic diseases is not well understood. Since body mass index is a suboptimal measure of body fat content, we investigated the relationship of fat mass measured by dual-energy X-ray absorptiometry with circulating cardiometabolic proteins. We used data from a population-based cohort of 4950 Swedish women (55-85 years), divided into discovery and replication samples; 276 proteins were assessed with three Olink Proseek Multiplex panels. We used random forest to identify the most relevant biomarker candidates related to fat mass index (FMI), multivariable linear regression to further investigate the associations between FMI characteristics and circulating proteins adjusted for potential confounders, and principal component analysis (PCA) for the detection of common covariance patterns among the proteins. Total FMI was associated with 66 proteins following adjustment for multiple testing in discovery and replication multivariable analyses. Five proteins not previously associated with body size were associated with either lower FMI (calsyntenin-2 (CLSTN2), kallikrein-10 (KLK10)), or higher FMI (scavenger receptor cysteine-rich domain-containing group B protein (SSC4D), trem-like transcript 2 protein (TLT-2), and interleukin-6 receptor subunit alpha (IL-6RA)). PCA provided an efficient summary of the main variation in FMI-related circulating proteins involved in glucose and lipid metabolism, appetite regulation, adipocyte differentiation, immune response and inflammation. Similar patterns were observed for regional fat mass measures. This is the first large study showing associations between fat mass and circulating cardiometabolic proteins. Proteins not previously linked to body size are implicated in modulation of postsynaptic signals, inflammation, and carcinogenesis.
Sections du résumé
BACKGROUND
The underlying molecular pathways for the effect of excess fat mass on cardiometabolic diseases is not well understood. Since body mass index is a suboptimal measure of body fat content, we investigated the relationship of fat mass measured by dual-energy X-ray absorptiometry with circulating cardiometabolic proteins.
METHODS
We used data from a population-based cohort of 4950 Swedish women (55-85 years), divided into discovery and replication samples; 276 proteins were assessed with three Olink Proseek Multiplex panels. We used random forest to identify the most relevant biomarker candidates related to fat mass index (FMI), multivariable linear regression to further investigate the associations between FMI characteristics and circulating proteins adjusted for potential confounders, and principal component analysis (PCA) for the detection of common covariance patterns among the proteins.
RESULTS
Total FMI was associated with 66 proteins following adjustment for multiple testing in discovery and replication multivariable analyses. Five proteins not previously associated with body size were associated with either lower FMI (calsyntenin-2 (CLSTN2), kallikrein-10 (KLK10)), or higher FMI (scavenger receptor cysteine-rich domain-containing group B protein (SSC4D), trem-like transcript 2 protein (TLT-2), and interleukin-6 receptor subunit alpha (IL-6RA)). PCA provided an efficient summary of the main variation in FMI-related circulating proteins involved in glucose and lipid metabolism, appetite regulation, adipocyte differentiation, immune response and inflammation. Similar patterns were observed for regional fat mass measures.
CONCLUSIONS
This is the first large study showing associations between fat mass and circulating cardiometabolic proteins. Proteins not previously linked to body size are implicated in modulation of postsynaptic signals, inflammation, and carcinogenesis.
Identifiants
pubmed: 37550405
doi: 10.1038/s41366-023-01351-z
pii: 10.1038/s41366-023-01351-z
pmc: PMC10599989
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1043-1049Informations de copyright
© 2023. The Author(s).
Références
J Clin Invest. 1997 Dec 1;100(11):2752-6
pubmed: 9389739
Psychol Aging. 2013 Mar;28(1):262-74
pubmed: 23276211
J Am Heart Assoc. 2019 Jun 4;8(11):e011860
pubmed: 31433701
J Clin Endocrinol Metab. 2004 Apr;89(4):1879-84
pubmed: 15070959
Epidemiology. 2011 Sep;22(5):745
pubmed: 21811114
Nat Metab. 2020 Oct;2(10):1135-1148
pubmed: 33067605
Sci Rep. 2015 Nov 30;5:17426
pubmed: 26616394
Metab Syndr Relat Disord. 2019 Jun;17(5):272-279
pubmed: 30883260
Pharmacoeconomics. 2015 Jul;33(7):673-89
pubmed: 25471927
Metabolism. 2019 Mar;92:61-70
pubmed: 30586573
Int J Obes (Lond). 2021 Oct;45(10):2221-2229
pubmed: 34226637
Eur J Prev Cardiol. 2019 Nov;26(17):1865-1873
pubmed: 31409108
Clin Sci (Lond). 2018 Jun 21;132(12):1243-1252
pubmed: 29930142
Obesity (Silver Spring). 2020 Jan;28(1):178-186
pubmed: 31804015
Quant Imaging Med Surg. 2020 Aug;10(8):1687-1698
pubmed: 32742961
Biochem Biophys Res Commun. 2018 May 15;499(3):584-593
pubmed: 29621546
J Am Heart Assoc. 2021 Jan 5;10(1):e018020
pubmed: 33372532
Biomolecules. 2020 Mar 23;10(3):
pubmed: 32210034
BMC Med. 2021 Dec 15;19(1):320
pubmed: 34906131
Immunogenetics. 2002 Dec;54(9):621-34
pubmed: 12466895
Cold Spring Harb Perspect Biol. 2014 Sep 04;6(10):a016295
pubmed: 25190079
Sci Rep. 2020 May 13;10(1):7913
pubmed: 32404980
J Intern Med. 2017 Feb;281(2):167-178
pubmed: 27665750
J Bone Miner Res. 2021 Jul;36(7):1288-1299
pubmed: 33784427
Eur Heart J. 2020 Jan 7;41(2):221-226
pubmed: 31195408
Neuropsychopharmacology. 2016 Feb;41(3):802-10
pubmed: 26171716
Biol Psychiatry. 2009 Apr 15;65(8):671-9
pubmed: 19058786
Metabolism. 2015 Jan;64(1):24-34
pubmed: 25199978
Mol Metab. 2019 Jan;19:86-96
pubmed: 30392760
Nat Commun. 2021 Feb 24;12(1):1279
pubmed: 33627659
Trends Endocrinol Metab. 2009 May;20(4):153-62
pubmed: 19349193
PLoS One. 2011;6(11):e27694
pubmed: 22096613
Metabolites. 2019 Jul 06;9(7):
pubmed: 31284606
Hypertension. 2016 Aug;68(2):392-400
pubmed: 27296994
Drug Discov Today Ther Strateg. 2008;5(1):53-61
pubmed: 19343099
J Leukoc Biol. 2016 Jul;100(1):177-84
pubmed: 26753760
Clin Biochem. 2021 Jun;92:9-18
pubmed: 33713636
PLoS One. 2009 Sep 15;4(9):e7038
pubmed: 19753111
Eur J Epidemiol. 2008;23(10):661-7
pubmed: 18704705
Endocrinology. 2014 Jun;155(6):2133-43
pubmed: 24654786
Bioinformatics. 2019 Mar 15;35(6):972-980
pubmed: 30165467
Biomolecules. 2019 Dec 03;9(12):
pubmed: 31816846
Nat Rev Immunol. 2010 Feb;10(2):89-102
pubmed: 20081871